CRSP – crispr therapeutics ag - common shares (US:NASDAQ)
Stock Stats
News
1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Celebrating a Milestone: Engineering Tomorrow Reaches 1 Million Students [Yahoo! Finance]
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? [Yahoo! Finance]
Form SC 13G/A CRISPR Therapeutics AG Filed by: ARK Investment Management LLC
Form 4 CRISPR Therapeutics AG For: Dec 02 Filed by: Kulkarni Samarth
Form 4 CRISPR Therapeutics AG For: Nov 11 Filed by: Kulkarni Samarth
Form 144 CRISPR Therapeutics AG Filed by: Kulkarni Samarth
Form 10-Q CRISPR Therapeutics AG For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.